Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2024	Sep. 30, 2023	Sep. 30, 2024	Sep. 30, 2023
Revenues:
License and other revenues				$ 3,500
Expenses:
Royalties		30		1,605
Research and development	8,941	7,148	25,366	23,712
General and administrative	6,404	4,156	22,173	13,174
Gain on operating lease right-of-use assets				(1,065)
Total expenses	15,345	11,334	47,539	37,426
Loss from operations	(15,345)	(11,334)	(47,539)	(33,926)
Interest income	1,189	593	3,223	1,374
Interest expense	(1,102)	(105)	(3,126)	(309)
Change in fair value of warrant and derivative liabilities	(15,156)	(1,101)	(7,530)	(7,465)
Other income	145	111	531	2,729
Net Loss	$ (30,269)	$ (11,836)	$ (54,441)	$ (37,597)
Basic loss per common share	$ (0.63)	$ (0.48)	$ (1.41)	$ (1.89)
Dilutive loss per common share	$ (0.63)	$ (0.48)	$ (1.41)	$ (1.89)
Weighted average number of common shares outstanding - basic	48,081,758	24,797,564	38,504,273	19,942,613
Weighted average number of common shares outstanding - diluted	48,081,758	24,797,564	38,504,273	19,942,613
Other comprehensive income (loss):
Change in unrealized gains (losses) related to available-for-sale debt securities	$ 50	$ (33)	$ (18)	$ 1
Foreign currency translation adjustments		29		29
Comprehensive loss	$ (30,219)	$ (11,840)	$ (54,459)	$ (37,567)